Sargent Investment Group’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,670
| Closed | -$4.72K | – | 243 |
|
|
2024
Q4 | $4.72K | Sell |
11,670
-9,790
| -46% | -$3.96K | ﹤0.01% | 235 |
|
|
2024
Q3 | $69.5K | Hold |
21,460
| – | – | 0.01% | 208 |
|
|
2024
Q2 | $64.4K | Sell |
21,460
-358
| -2% | -$1.07K | 0.01% | 213 |
|
|
2024
Q1 | $101K | Buy |
+21,818
| New | +$101K | 0.02% | 193 |
|
|
2023
Q4 | – | Sell |
-16,206
| Closed | -$48.6K | – | 211 |
|
|
2023
Q3 | $48.6K | Sell |
16,206
-300
| -2% | -$900 | 0.01% | 199 |
|
|
2023
Q2 | $40.6K | Buy |
16,506
+2,189
| +15% | +$5.39K | 0.01% | 196 |
|
|
2023
Q1 | $33.9K | Buy |
+14,317
| New | +$33.9K | 0.01% | 194 |
|